Q4 2024 Earnings Call Transcript March 13, 2025 aTyr Pharma, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23. Operator: Good afternoon, ladies and gentlemen, and ...
Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.
Tata Motors leads Nifty 100 companies in R&D spending, focusing on mobility solutions and alternative fuel technologies.
Shilpa Medicare has announced that the United States Food and Drug Administration (USFDA) conducted an inspection at Unit-2 of its subsidiary, Shilpa Pharma Lifesciences, located in Raichur, with zero ...
Akeso's immunotherapy drug allowed half of its patients to go 11.1 months without their condition worsening Chinese drug ...
Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate ...
The infection spreads to the brain or spinal column.” Others “suffer a sudden, uncontrollable hemorrhage, leading to a quick ...
In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...
Mr Emeje discusses the potential of traditional medicine to create millions of jobs, the need for academic recognition, and his vision for its integration into Nigeria’s healthcare system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results